Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]PARPi PET/MR Imaging in Brain Tumors
NCT04173104Phase 1Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2019
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]PARPi in brain cancer, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Maximum Standardized Uptake Value at 24 weeks. Started Nov 2019; status: completed.
02
Drugs
[18F]PARPi
03
Conditions
brain cancer
Beyond the preview
Go deeper on NCT04173104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04173104.